GKB Ophthalmics

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE265D01015
  • NSEID: GKB
  • BSEID: 533212
INR
56.98
-2.01 (-3.41%)
BSENSE

Nov 20

BSE+NSE Vol: 4.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "56.98",
    "chg": -2.01,
    "chgp": "-3.41%",
    "dir": -1,
    "prev_price": "58.99",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "Healthcare Services",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE265D01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.54 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4264793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GKBOphthalmicsL_mojoScore_4264793.png",
        "date": "2026-11-17 08:35:54",
        "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of deteriorating technical indicators, cautious valuation metrics, and mixed financial trends. Despite recent positive earnings growth, concerns over long-term fundamentals and technical signals have prompted a reassessment of the stock’s outlook."
      },
      {
        "title": "GKB Ophthalmics Upgraded to Hold on Improved Technicals and Financial Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gkb-ophthalmics-upgraded-to-hold-on-improved-technicals-and-financial-performance-4230664",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/GKBOphthalmicsL_mojoScore_4230664.png",
        "date": "2026-10-20 08:33:39",
        "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The company’s recent quarterly results, combined with a bullish shift in technical trends, have prompted analysts to revise their outlook, signalling cautious optimism for this healthcare services micro-cap."
      },
      {
        "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Weak Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financials-and-weak-technicals-4225005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/GKBOphthalmicsL_mojoScore_4225005.png",
        "date": "2026-10-14 08:22:13",
        "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a combination of deteriorating technical indicators, weak long-term fundamentals, and mixed financial trends. Despite recent positive quarterly results, the company’s overall outlook has been tempered by underperformance against benchmarks and a shift in technical momentum."
      },
      {
        "title": "GKB Ophthalmics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gkb-ophthalmics-ltd-surges-to-upper-circuit-on-strong-buying-pressure-4201420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GKBOphthalmicsL_stocks_hitting_upper_circuit_4201420.png",
        "date": "2026-09-22 12:00:08",
        "description": "At Rs 76.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. GKB Ophthalmics Ltd locked at its upper circuit of 10% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "GKB Ophthalmics Ltd Locks at Upper Circuit With 8.6% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gkb-ophthalmics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4176240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GKBOphthalmicsL_stocks_hitting_upper_circuit_4176240.png",
        "date": "2026-08-31 12:00:08",
        "description": "At Rs 68.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. GKB Ophthalmics Ltd locked at its upper circuit of 10% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 17,
    "sid": "360373",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2026",
      "details": "Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated financial Results for the quarter and half year ended September 302026 published in Business Standard ( English Edition) and on Pudhari (Marathi) dated November 14 2026.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.",
      "datetime": "12-Nov-2026",
      "details": "Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2026.",
      "datetime": "12-Nov-2026",
      "details": "The meeting of the Board of Directors of the company was held on November 12 2026 which has inter-alia considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2026 | Source : BSE

Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated financial Results for the quarter and half year ended September 302026 published in Business Standard ( English Edition) and on Pudhari (Marathi) dated November 14 2026.

Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.

12-Nov-2026 | Source : BSE

Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026.

Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2026.

12-Nov-2026 | Source : BSE

The meeting of the Board of Directors of the company was held on November 12 2026 which has inter-alia considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available